Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Drug Rediscovery Protocol (DRUP Trial) (DRUP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02925234
Recruitment Status : Recruiting
First Posted : October 5, 2016
Last Update Posted : October 27, 2021
Sponsor:
Collaborators:
Amgen
AstraZeneca
Bayer
Bristol-Myers Squibb
Novartis
Roche Pharma AG
Merck Sharp & Dohme LLC
Boehringer Ingelheim
Ipsen
Eisai Inc.
Pfizer
Clovis Oncology, Inc.
Eli Lilly and Company
Janssen, LP
Information provided by (Responsible Party):
The Netherlands Cancer Institute